▶ 調査レポート

世界のペメトレキセド市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Pemetrexed Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界のペメトレキセド市場 2021:企業別、地域別、種類・用途別 / Global Pemetrexed Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X13448資料のイメージです。• レポートコード:GIR-105X13448
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ペメトレキセドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペメトレキセドの種類別市場規模(100mg、500mg)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ペメトレキセドの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Eli Lilly、Abbott Laboratories、Cadila Healthcare、Eagle Pharmaceuticals、Stada Arzneimittel
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:100mg、500mg
・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン薬局
・ペメトレキセドの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ペメトレキセドのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ペメトレキセドのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ペメトレキセドの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ペメトレキセドの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pemetrexed market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pemetrexed size is estimated to be xx million in 2020 from USD 1813.5 million in 2019, with a change of XX% between 2019 and 2020. The global Pemetrexed market size is expected to grow at a CAGR of 0.7% for the next five years.

Market segmentation
Pemetrexed market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
100mg
500mg

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Pemetrexed market are listed below:
Eli Lilly
Abbott Laboratories
Cadila Healthcare
Eagle Pharmaceuticals
Stada Arzneimittel

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Pemetrexed Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pemetrexed Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg
1.2.3 500mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Pemetrexed Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pemetrexed Market Size & Forecast
1.4.1 Global Pemetrexed Sales in Value (2016-2026))
1.4.2 Global Pemetrexed Sales in Volume (2016-2026)
1.4.3 Global Pemetrexed Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pemetrexed Production Capacity Analysis
1.5.1 Global Pemetrexed Total Production Capacity (2016-2026)
1.5.2 Global Pemetrexed Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pemetrexed Market Drivers
1.6.2 Pemetrexed Market Restraints
1.6.3 Pemetrexed Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Pemetrexed Product and Services
2.1.4 Eli Lilly Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Pemetrexed Product and Services
2.2.4 Abbott Laboratories Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Cadila Healthcare
2.3.1 Cadila Healthcare Details
2.3.2 Cadila Healthcare Major Business
2.3.3 Cadila Healthcare Pemetrexed Product and Services
2.3.4 Cadila Healthcare Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Eagle Pharmaceuticals
2.4.1 Eagle Pharmaceuticals Details
2.4.2 Eagle Pharmaceuticals Major Business
2.4.3 Eagle Pharmaceuticals Pemetrexed Product and Services
2.4.4 Eagle Pharmaceuticals Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Stada Arzneimittel
2.5.1 Stada Arzneimittel Details
2.5.2 Stada Arzneimittel Major Business
2.5.3 Stada Arzneimittel Pemetrexed Product and Services
2.5.4 Stada Arzneimittel Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pemetrexed Sales by Manufacturer
3.1 Global Pemetrexed Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pemetrexed Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pemetrexed
3.4 Market Concentration Rate
3.4.1 Top 3 Pemetrexed Manufacturer Market Share
3.4.2 Top 6 Pemetrexed Manufacturer Market Share
3.5 Global Pemetrexed Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pemetrexed Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pemetrexed Market Size by Region
4.1.1 Global Pemetrexed Sales in Volume by Region (2016-2026)
4.1.2 Global Pemetrexed Revenue by Region (2016-2026)
4.2 North America Pemetrexed Revenue (2016-2026)
4.3 Europe Pemetrexed Revenue (2016-2026)
4.4 Asia-Pacific Pemetrexed Revenue (2016-2026)
4.5 South America Pemetrexed Revenue (2016-2026)
4.6 Middle East and Africa Pemetrexed Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pemetrexed Sales in Volume by Type (2016-2026)
5.2 Global Pemetrexed Revenue by Type (2016-2026)
5.3 Global Pemetrexed Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pemetrexed Sales in Volume by Application (2016-2026)
6.2 Global Pemetrexed Revenue by Application (2016-2026)
6.3 Global Pemetrexed Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pemetrexed Sales by Type (2016-2026)
7.2 North America Pemetrexed Sales by Application (2016-2026)
7.3 North America Pemetrexed Market Size by Country
7.3.1 North America Pemetrexed Sales in Volume by Country (2016-2026)
7.3.2 North America Pemetrexed Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pemetrexed Sales by Type (2016-2026)
8.2 Europe Pemetrexed Sales by Application (2016-2026)
8.3 Europe Pemetrexed Market Size by Country
8.3.1 Europe Pemetrexed Sales in Volume by Country (2016-2026)
8.3.2 Europe Pemetrexed Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pemetrexed Sales by Type (2016-2026)
9.2 Asia-Pacific Pemetrexed Sales by Application (2016-2026)
9.3 Asia-Pacific Pemetrexed Market Size by Region
9.3.1 Asia-Pacific Pemetrexed Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pemetrexed Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pemetrexed Sales by Type (2016-2026)
10.2 South America Pemetrexed Sales by Application (2016-2026)
10.3 South America Pemetrexed Market Size by Country
10.3.1 South America Pemetrexed Sales in Volume by Country (2016-2026)
10.3.2 South America Pemetrexed Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pemetrexed Sales by Type (2016-2026)
11.2 Middle East & Africa Pemetrexed Sales by Application (2016-2026)
11.3 Middle East & Africa Pemetrexed Market Size by Country
11.3.1 Middle East & Africa Pemetrexed Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pemetrexed Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pemetrexed Typical Distributors
12.3 Pemetrexed Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Pemetrexed Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pemetrexed Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Pemetrexed Product and Services
Table 6. Eli Lilly Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Pemetrexed Product and Services
Table 10. Abbott Laboratories Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. Cadila Healthcare Major Business
Table 13. Cadila Healthcare Pemetrexed Product and Services
Table 14. Cadila Healthcare Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Eagle Pharmaceuticals Major Business
Table 17. Eagle Pharmaceuticals Pemetrexed Product and Services
Table 18. Eagle Pharmaceuticals Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 20. Stada Arzneimittel Major Business
Table 21. Stada Arzneimittel Pemetrexed Product and Services
Table 22. Stada Arzneimittel Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Pemetrexed Sales by Manufacturer (2019-2021e) & (Units)
Table 24. Global Pemetrexed Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Pemetrexed, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Pemetrexed Production Capacity by Company, (Units): 2020 VS 2021
Table 27. Head Office and Pemetrexed Production Site of Key Manufacturer
Table 28. Global Pemetrexed Sales by Region (2016-2021e) & (Units)
Table 29. Global Pemetrexed Sales by Region (2021-2026) & (Units)
Table 30. Global Pemetrexed Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Pemetrexed Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 33. Global Pemetrexed Sales by Type (2021-2026) & (Units)
Table 34. Global Pemetrexed Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Pemetrexed Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Pemetrexed Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Pemetrexed Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 39. Global Pemetrexed Sales by Application (2021-2026) & (Units)
Table 40. Global Pemetrexed Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Pemetrexed Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Pemetrexed Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Pemetrexed Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Pemetrexed Sales by Country (2016-2021e) & (Units)
Table 45. North America Pemetrexed Sales by Country (2021-2026) & (Units)
Table 46. North America Pemetrexed Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Pemetrexed Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 49. North America Pemetrexed Sales by Type (2021-2026) & (Units)
Table 50. North America Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 51. North America Pemetrexed Sales by Application (2021-2026) & (Units)
Table 52. Europe Pemetrexed Sales by Country (2016-2021e) & (Units)
Table 53. Europe Pemetrexed Sales by Country (2021-2026) & (Units)
Table 54. Europe Pemetrexed Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Pemetrexed Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 57. Europe Pemetrexed Sales by Type (2021-2026) & (Units)
Table 58. Europe Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 59. Europe Pemetrexed Sales by Application (2021-2026) & (Units)
Table 60. Asia-Pacific Pemetrexed Sales by Region (2016-2021e) & (Units)
Table 61. Asia-Pacific Pemetrexed Sales by Region (2021-2026) & (Units)
Table 62. Asia-Pacific Pemetrexed Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Pemetrexed Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 65. Asia-Pacific Pemetrexed Sales by Type (2021-2026) & (Units)
Table 66. Asia-Pacific Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 67. Asia-Pacific Pemetrexed Sales by Application (2021-2026) & (Units)
Table 68. South America Pemetrexed Sales by Country (2016-2021e) & (Units)
Table 69. South America Pemetrexed Sales by Country (2021-2026) & (Units)
Table 70. South America Pemetrexed Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Pemetrexed Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 73. South America Pemetrexed Sales by Type (2021-2026) & (Units)
Table 74. South America Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 75. South America Pemetrexed Sales by Application (2021-2026) & (Units)
Table 76. Middle East & Africa Pemetrexed Sales by Country (2016-2021e) & (Units)
Table 77. Middle East & Africa Pemetrexed Sales by Country (2021-2026) & (Units)
Table 78. Middle East & Africa Pemetrexed Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Pemetrexed Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Pemetrexed Sales by Type (2016-2021e) & (Units)
Table 81. Middle East & Africa Pemetrexed Sales by Type (2021-2026) & (Units)
Table 82. Middle East & Africa Pemetrexed Sales by Application (2016-2021e) & (Units)
Table 83. Middle East & Africa Pemetrexed Sales by Application (2021-2026) & (Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Pemetrexed Typical Distributors
Table 87. Pemetrexed Typical Customers
List of Figures
Figure 1. Pemetrexed Picture
Figure 2. Global Pemetrexed Sales Market Share by Type in 2020
Figure 3. 100mg
Figure 4. 500mg
Figure 5. Global Pemetrexed Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Pemetrexed Market Size, (USD Million) & (Units): 2020 VS 2021 VS 2026
Figure 10. Global Pemetrexed Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Pemetrexed Sales (2016-2026) & (Units)
Figure 31. Global Pemetrexed Production Capacity (2016-2026) & (Units)
Figure 32. Global Pemetrexed Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Pemetrexed Market Drivers
Figure 34. Pemetrexed Market Restraints
Figure 35. Pemetrexed Market Trends
Figure 36. Global Pemetrexed Sales Market Share by Manufacturer in 2020
Figure 37. Global Pemetrexed Revenue Market Share by Manufacturer in 2020
Figure 38. Pemetrexed Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Pemetrexed Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Pemetrexed Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Pemetrexed Sales Market Share by Region (2016-2026)
Figure 42. Global Pemetrexed Revenue Market Share by Region (2016-2026)
Figure 43. North America Pemetrexed Revenue (2016-2026) & (USD Million)
Figure 44. Europe Pemetrexed Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Pemetrexed Revenue (2016-2026) & (USD Million)
Figure 46. South America Pemetrexed Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Pemetrexed Revenue (2016-2026) & (USD Million)
Figure 48. Global Pemetrexed Sales Market Share by Type (2016-2026)
Figure 49. Global Pemetrexed Revenue Market Share by Type (2016-2026)
Figure 50. Global Pemetrexed Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Pemetrexed Sales Market Share by Application (2016-2026)
Figure 52. Global Pemetrexed Revenue Market Share by Application (2016-2026)
Figure 53. Global Pemetrexed Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Pemetrexed Sales Market Share by Country (2016-2026)
Figure 55. North America Pemetrexed Revenue Market Share by Country (2016-2026)
Figure 56. North America Pemetrexed Sales Market Share by Type (2016-2026)
Figure 57. North America Pemetrexed Sales Market Share by Application (2016-2026)
Figure 58. Europe Pemetrexed Sales Market Share by Country (2016-2026)
Figure 59. Europe Pemetrexed Revenue Market Share by Country (2016-2026)
Figure 60. Europe Pemetrexed Sales Market Share by Type (2016-2026)
Figure 61. Europe Pemetrexed Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Pemetrexed Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Pemetrexed Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pemetrexed Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pemetrexed Sales Market Share by Application (2016-2026)
Figure 66. South America Pemetrexed Sales Market Share by Country (2016-2026)
Figure 67. South America Pemetrexed Revenue Market Share by Country (2016-2026)
Figure 68. South America Pemetrexed Sales Market Share by Type (2016-2026)
Figure 69. South America Pemetrexed Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pemetrexed Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pemetrexed Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pemetrexed Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Pemetrexed Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source